The adaptation of lipid nanocapsule formulations for blood administration in animals

International Journal of Pharmaceutics

Volumn 379, Issue 2, 2009, Pages 266-269

  Hureaux, J ^a,b   Lagarce, F ^a,b   Gagnadoux, F ^a,b   Clavreul, A ^b   Benoit, J P ^a,b   Urban, T ^a,b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ D'ANGERS   (France)

Author keywords

Animal experimentation; Drug storage; Genetically modified; Intravenous injections; Lipid nanocapsule; Paclitaxel; Plants

Indexed keywords

LIPID NANOCAPSULE; LIQUID NITROGEN; NANOCAPSULE; PACLITAXEL; PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ACID BASE BALANCE; ACIDOSIS; ANIMAL EXPERIMENT; ARTICLE; BLOOD PH; CONTROLLED STUDY; CRYOPRESERVATION; CYTOTOXICITY; DRUG RELEASE; DRUG STORAGE; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SOYBEAN; TRANSGENIC ORGANISM;

ANIMALS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; FEMALE; HUMANS; LIPIDS; NANOCAPSULES; ORGANISMS, GENETICALLY MODIFIED; RATS; RATS, SPRAGUE-DAWLEY;

EID: 68949199436     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.05.033     Document Type: Article

References (13)

1. Allard E., Passirani C., Garcion E., Pigeon P., Vessières A., Jaouen G., and Benoit J. Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas. J. Control Release 130 (2008) 146-153
2. Diehl K.H., Hull R., Morton D., Pfister R., Rabemampianina Y., Smith D., Vidal J.M., and van de Vorstenbosch C. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J. Appl. Toxicol. 21 (2001) 15-23
3. Garcion E., Lamprecht A., Heurtault B., Paillard A., Aubert-Pouessel A., Denizot B., Menei P., and Benoit J.P. A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol. Cancer Ther. 5 (2006) 1710-1722
4. Heurtault B., Saulnier P., Pech B., Proust J.E., and Benoit J.P. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res. 19 (2002) 875-880
5. Khalid M.N., Simard P., Hoarau D., Dragomir A., and Leroux J.C. Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors. Pharm. Res. 23 (2006) 752-758
6. Lacœuille F., Garcion E., Benoit J.P., and Lamprecht A. Lipid nanocapsules for intracellular drug delivery of anticancer drugs. J. Nanosci. Nanotechnol. 7 (2007) 4612-4617
7. Lamprecht A., and Benoit J.P. Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. J. Control Release 112 (2006) 208-213
8. Lamprecht A., Bouligand Y., and Benoit J.P. New lipid nanocapsules exhibit sustained release properties for amiodarone. J. Control Release 84 (2002) 59-68
9. Lamprecht A., Saumet J.L., Roux J., and Benoit J.P. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. Int. J. Pharm. 278 (2004) 407-414
10. Lim S. Metabolic acidosis. Acta Med. Indones. 39 (2007) 145-150
11. Malzert-Freon A., Vrignaud S., Saulnier P., Lisowski V., Benoit J.P., and Rault S. Formulation of sustained release nanoparticles loaded with a tripentone, a new anticancer agent. Int. J. Pharm. 320 (2006) 157-164
12. Peltier S., Oger J.M., Lagarce F., Couet W., and Benoit J.P. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules. Pharm. Res. 23 (2006) 1243-1250
13. U.S. Food and Drug Administration, 2002. Drugs, Biologics, and Medical Devices Derived from Bioengineered Plants for Use in Humans and Animals (http://www.fda.gov/cber/gdlns/bioplant.pdf).